Ramón García‐Sánz
0000-0003-4120-2787
Publication & Citation Trends
Publications
0 total
Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancers.
Cited by 0
Semantic Scholar
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.
Cited by 0
Semantic Scholar
Multiomic Characterization of Clonotypic B Cells in Patients with Monoclonal Gammopathies
Cited by 0
Semantic Scholar
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma OA
Cited by 60
Semantic Scholar
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group OA
Cited by 25
Semantic Scholar
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry OA
Cited by 28
Semantic Scholar
Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL) OA
Cited by 3
Semantic Scholar
P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA. OA
Cited by 0
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(280)
Chronic Lymphocytic Leukemia Research
(209)
Lymphoma Diagnosis and Treatment
(187)
Protein Degradation and Inhibitors
(89)
Acute Myeloid Leukemia Research
(69)
Affiliations
Université Claude Bernard Lyon 1
Universidad Complutense de Madrid
Centre National de la Recherche Scientifique
Johnson & Johnson (United States)
Consejo Superior de Investigaciones Científicas